Isolated hypertrophy of the basal ventricular septum: Characteristics of patients with and without outflow tract obstruction

International Journal of Cardiology

Volumn 173, Issue 3, 2014, Pages 487-493

  Ranasinghe, Isuru ^a   Ayoub, Chadi ^a   Cheruvu, Chaitu ^a   Freedman, Saul B ^a   Yiannikas, John ^a  

^a ANZAC Research Institute   (Australia)

Author keywords

Cardiac hypertrophy; Epidemiology; Outflow tract obstruction; Sigmoid septum

Indexed keywords

AGE; AGED; ARTICLE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FAMILY HISTORY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE PRESSURE; HEART VENTRICLE SEPTUM; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; ISOLATED BASAL SEPTAL HYPERTROPHY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; COHORT ANALYSIS; COMPARATIVE STUDY; ECHOGRAPHY; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; VENTRICULAR OUTFLOW OBSTRUCTION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; VENTRICULAR OUTFLOW OBSTRUCTION; VENTRICULAR SEPTUM;

EID: 84899540363     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.03.078     Document Type: Article

References (37)

1. B.J. Maron, W.J. McKenna, and G.K. Danielson et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents and the European Society of Cardiology Committee for Practice Guidelines J Am Coll Cardiol 42 2003 1687 1713
2. B.J. Maron Hypertrophic cardiomyopathy: a systematic review JAMA 287 2002 1308 1320
3. K. Iida, Y. Sugishita, and R. Ajisaka et al. sigmoid septum causing left ventricular outflow tract obstruction: a case report J Cardiogr. 16 1986 237 247
4. K. Ozaki, I. Sakuma, and K. Mitsuma et al. Effect of cibenzoline and atenolol administration on dynamic left ventricular obstruction due to sigmoid-shaped septum Circ J 72 2008 2087 2091
5. I. Ranasinghe, T. Yeoh, and J. Yiannikas Negative ionotropic agents for the treatment of left ventricular outflow tract obstruction due to sigmoid septum and concentric left ventricular hypertrophy Heart Lung Circ 20 2011 579 586
6. B.J. Maron, J.M. Gardin, J.M. Flack, S.S. Gidding, T.T. Kurosaki, and D.E. Bild Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the cardia study. Coronary artery risk development in (young) adults Circulation 92 1995 785 789
7. B.J. Maron, R. Mathenge, S.A. Casey, L.C. Poliac, and T.F. Longe Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communities J Am Coll Cardiol 33 1999 1590 1595
8. Y. Hada, T. Sakamoto, and K. Amano et al. Prevalence of hypertrophic cardiomyopathy in a population of adult Japanese workers as detected by echocardiographic screening Am J Cardiol 59 1987 183 184
9. Y. Zou, L. Song, and Z. Wang et al. Prevalence of idiopathic hypertrophic cardiomyopathy in china: a population-based echocardiographic analysis of 8080 adults Am J Med 116 2004 14 18
10. R.O. Bonow, B.A. Carabello, and C. Kanu et al. Acc/aha 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease): developed in collaboration with the society of cardiovascular anesthesiologists: endorsed by the society for cardiovascular angiography and interventions and the society of thoracic surgeons Circulation 114 2006 e84 e231
11. I. Hajjar, J.M. Kotchen, and T.A. Kotchen Hypertension: trends in prevalence, incidence, and control Annu Rev Public Health 27 2006 465 490
12. K. Wolf-Maier, R.S. Cooper, and J.R. Banegas et al. Hypertension prevalence and blood pressure levels in 6 european countries, Canada, and the United States JAMA 289 2003 2363 2369
13. B.M. Egan, Y. Zhao, and R.N. Axon Us trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008 JAMA 303 2010 2043 2050
14. R.M. Lang, M. Bierig, and R.B. Devereux et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
15. M.V. Sherrid, G. Pearle, and D.Z. Gunsburg Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy Circulation 97 1998 41 47
16. D.H. Kwon, N.G. Smedira, and Z.B. Popovic et al. Steep left ventricle to aortic root angle and hypertrophic obstructive cardiomyopathy: study of a novel association using three-dimensional multimodality imaging Heart 95 2009 1784 1791
17. H.G. Klues, A. Schiffers, and B.J. Maron Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients J Am Coll Cardiol 26 1995 1699 1708
18. J. Binder, S.R. Ommen, and B.J. Gersh et al. Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: Septal morphological features predict the presence of myofilament mutations Mayo Clin Proc 81 2006 459 467
19. A.T. Turer, Z. Samad, and A.M. Valente et al. Anatomic and clinical correlates of septal morphology in hypertrophic cardiomyopathy Eur J Echocardiogr 12 2011 131 139
20. I. Belenkie, R.P. MacDonald, and E.R. Smith Localized septal hypertrophy: part of the spectrum of hypertrophic cardiomyopathy or an incidental echocardiographic finding? Am Heart J 115 1988 385 390
21. L.M. Shapiro, A.P. Howat, P.A. Crean, and C.J. Westgate An echocardiographic study of localized subaortic hypertrophy Eur Heart J 7 1986 127 132
22. T. Diaz, M.J. Pencina, and E.J. Benjamin et al. Prevalence, clinical correlates, and prognosis of discrete upper septal thickening on echocardiography: the Framingham heart study Echocardiography 26 2009 247 253
23. M.V. Sherrid, C.K. Chu, E. Delia, A. Mogtader, and E.M. Dwyer Jr. An echocardiographic study of the fluid mechanics of obstruction in hypertrophic cardiomyopathy J Am Coll Cardiol 22 1993 816 825
24. M.V. Sherrid, D.Z. Gunsburg, S. Moldenhauer, and G. Pearle Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy J Am Coll Cardiol 36 2000 1344 1354
25. A.D. Maslow, M.M. Regan, J.M. Haering, R.G. Johnson, and R.A. Levine Echocardiographic predictors of left ventricular outflow tract obstruction and systolic anterior motion of the mitral valve after mitral valve reconstruction for myxomatous valve disease J Am Coll Cardiol 34 1999 2096 2104
26. F.N. Delling, D.Y. Sanborn, and R.A. Levine et al. Frequency and mechanism of persistent systolic anterior motion and mitral regurgitation after septal ablation in obstructive hypertrophic cardiomyopathy Am J Cardiol 100 2007 1691 1695
27. I. Olivotto, M.S. Maron, and A.S. Adabag et al. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy J Am Coll Cardiol 46 2005 480 487
28. M.S. Maron, I. Olivotto, and C. Harrigan et al. Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy Circulation 124 2011 40 47
29. H.G. Klues, B.J. Maron, A.L. Dollar, and W.C. Roberts Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy Circulation 85 1992 1651 1660
30. C.J. Harrigan, E. Appelbaum, and B.J. Maron et al. Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy Am J Cardiol 101 2008 668 673
31. C. Stollberger, J. Finsterer, and G. Blazek Left ventricular hypertrabeculation/noncompaction and association with additional cardiac abnormalities and neuromuscular disorders Am J Cardiol 90 2002 899 902
32. W.P. Fay, C.P. Taliercio, D.M. Ilstrup, A.J. Tajik, and B.J. Gersh Natural history of hypertrophic cardiomyopathy in the elderly J Am Coll Cardiol 16 1990 821 826
33. H.M. Lever, R.F. Karam, P.J. Currie, and B.P. Healy Hypertrophic cardiomyopathy in the elderly distinctions from the young based on cardiac shape Circulation 79 1989 580 589
34. D. Goor, C.W. Lillehei, and J.E. Edwards The "sigmoid septum" variation in the contour of the left ventricular outt Am J Roentgenol Radium Ther Nucl Med 107 1969 366 376
35. C.J. McLeod, J.M. Bos, and J.L. Theis et al. Histologic characterization of hypertrophic cardiomyopathy with and without myofilament mutations Am Heart J 158 5 2009 Nov 799 805
36. C.T. Ng, T.S. Chee, and L.F. Ling et al. Prevalence of hypertrophic cardiomyopathy on an electrocardiogram-based pre-participation screening programme in a young male south-east Asian population: results from the Singapore Armed Forces electrocardiogram and echocardiogram screening protocol Europace 13 2011 883 888
37. M. Sokolow, and T.P. Lyon The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads Am Heart J 37 1949 161 186